Lawmaker Urges FDA Not To Allow Off-Label Loophole
The chair of the U.S. House of Representatives Oversight Committee sent a letter to the U.S. Food and Drug Administration Friday, urging the agency to rethink a recent internal draft guidance...To view the full article, register now.
Already a subscriber? Click here to view full article